AlphaValue/Baader Europe on Friday downgraded molecular testing company Qiagen (QIA.F) to add from buy and increased its price target to 44.40 euros from 44.20 euros.
(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)